Treatment options for Alzheimer's disease;Les traitements de la maladie d'Alzheimer

PSN

Volumn 6, Issue 2, 2008, Pages 82-90

  Seux, M L ^a   De Rotrou, J ^a   Rigaud, A S ^a  

^a Paris Descartes University   (France)

Author keywords

Alzheimer's disease; Anticholinesterasic drug; Antiglutaminergic drug; Cognitive stimulation; Psychosocial interventions

Indexed keywords

EID: 49549116016     PISSN: 16398319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11836-008-0060-4     Document Type: Review

References (30)

1. AD2000 Collaborative Group 2004 Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial Lancet 363 2105 2115
2. S. Ancoli-Israël J.L. Martin D.F. Kripke 2002 Effect of light treatment on sleep and circadian rhythms in demented nursing home patients J Am Geriatr Soc 50 282 289
3. S. Auriacombe J.J. Pere Rivage Study Group 2003 No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment Curr Med Res Opin 18 715 717
4. S. Adam M. Van Der Linden A.C. Juillerat 2000 The cognitive management of daily life activities in patients with mild to moderate Alzheimer's disease in a day care center: a case report Neuropsychological rehabilitation 10 05 485 509
5. H. Brodaty A. Green A. Koschera 2003 Meta-analysis of psychosocial interventions for caregivers of people with dementia J Am Geriatric Soc 51 657 664
6. M. Brotons S.M. Kroger 2000 The impact of music therapy on language functionning in dementia J Music Ther 37 3 183 195
7. R. Bullock J. Touchon H. Bergman 2005 Riverstigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period Curr Med Res Opin 21 1317 1327
8. Clare L, Woods RT, Moniz Cook ED, et al. (2003) Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev 4: CD003260
9. D.D. Cooke L. McNally K.T. Mulligan 2001 Psychosocial interventions for caregivers of people with dementia: a systematic review Aging Ment Health 5 2 120 135
10. De Rotrou J (2008) Stimulation cognitive et vieillissement. In: Gérontologie préventive. Abrégés de médecine. Masson (sous presse)
11. M.L. Garcia de la Rocha A. Frank M. Galiano 2004 Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer's disease Neurology 63 12 2348 2353
12. P.F. Gasio K. Krauchi C. Cajochen 2003 Dawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderly Exp Gerontol 38 207 216
13. S.G. Gauthier 2005 Realizing early treatment benefits in dementia Eur J Neurol. 12 Suppl.3 11 16
14. D.S. Geldmacher G. Provenzano T. McRaae 2003 Donezepil is associated with delayed nursing home placement in patients with Alzheimer's disease J Am Geriatr Soc 51 7 937 944
15. S. Gildman M. Koller R. Back 2003 Clinical effects of Aβ immunization (AN1792) in patients with Alzheimer's disease in an interrupted trial Neurology 61 46 54
16. O. Hanon F. Forette 2004 Prevention of dementia: lessons form Syst-Eur and Progress J Neurol Sci 226 71 74
17. C. Holmes D. Wilkinson C. Dean 2004 The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer's disease Neurology 63 2 214 219
18. R.J. Howard E. Juszczak C.G. Ballard for the CALM-AD trial group 2007 Donepezil for the treatment of agitation in Alzheimer's disease N Engl J Med 357 1382 1392
19. R.C. Mohs R.S. Doody J.R. Morris 2001 A 1-year placebo-controlled preservation of function survival study of donezepil in AD patients Neurology 57 3 481 488
20. th, Washington DC, USA
21. C.W. Ritchie D. Ames T. Clayton 2004 Metaanalysis of randomized trials of the efficacy and safety of donepezil, galanthamine and rivastigmine for the treatment of Alzheimer's disease Am J Geriatr Psychiatry 12 358 369
22. T. Rousseau 1998 Thérapie cognitivocomportementale des troubles de la communication dans la démence de type alzheimer Rev Fr Psychiatrie Psychol Med 20 88 90
23. P. Tariot M. Farlow G. Grossberg 2004 Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donezepil JAMA 291 317 324
24. Thorgrimsen L, Spector A, Wiles A, et al. (2003) Aroma therapy for dementia. Cochrane Database Syst Rev 3: CD003150
25. Vink AC, Birks JS, Bruinsma MS, et al. (2004) Music therapy for people with dementia. Cochrane Database Syst Rev 3: CD003477
26. D.G. Wilkinson A.P. Passmore R. Bullock 2002 Étude multinationale, randomisée, de 12 semaines, comparant le donepezil et la rivastigmine chez de patients atteints de la maladie d'Alzheimer d'intensité légère à modérée Int J Clin Pract 56 441 446
27. B. Winblad K. Engelad H. Soinen 2001 A 1-year randomized placebo-controlled study of donezepil in patients with mild moderate Alzheimer's disease Neurology 57 489 495
28. B. Winblad L. Kilander S. Eriksson 2006 Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study Lancet 368 1507 1565
29. B. Winblad R.W. Jones Y. With 2007 Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials Dement Geriatr Cogn Disord 24 20 27
30. B. Woods L. Thorgrimsen A. Spector 2006 Improved quality of life and cognitive stimulation therapy in dementia Aging Ment Health 10 3 219 226